Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| BioSpring Gesellschaft für Biotechnologie mbH | Frankfurt am Main, Germany | Makes the active ingredient and tests it | Problems found, fixed voluntarilyNov 15, 2022 · 2 inspections |
| Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) | Langenargen, Germany | Makes it and tests it | Problems found, fixed voluntarilyMar 20, 2024 · 8 inspections |
| Genzyme Corporation | Northborough, MA, United States | Tests it, packages it and labels it | No problems foundAug 14, 2025 · 6 inspections |
| PPD Development Ireland Ltd. | Athlone, Ireland | Tests it | Problems found, fixed voluntarilyMar 9, 2023 · 4 inspections |
| Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Helmut-Vetter-Strasse) | Ravensburg, Germany | Tests it | Problems found, fixed voluntarilyJul 27, 2022 · 6 inspections |
Product details
- Generic drug
- Fitusiran: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 20 mg per 0.2 mL
- Approval
- NDA NDA219019
- On the market since
- Mar 28, 2025
- Package NDCs
58468-0347-1- Official label
- DailyMed (National Library of Medicine), updated Sep 16, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?